Drug Target ReviewNeural stem cell treatment may offer relief for MSDrug Target ReviewScientists have shown in mice that skin cells re-programmed into brain stem cells, transplanted into the central nervous system, help reduce inflammation and may be a… Continue reading
NYC-based immunotherapy startup Quentis comes to life with $48MFierceBiotechNYC-based immunotherapy startup Quentis comes to life with $48M. by Amirah Al Idrus |. Feb 27, 2018 7:30am. Quentis is the second New York City-based biotech to launch within a… Continue reading
|
Gilead’s Hunt And The Crispr Crapshoot (Podcast)
Seeking Alpha M&A in the pharma industry is often nothing more than a roll of the dice. CRISPR Therapeutics’ stock has shot up in the last two months with little or no obvious explanation. Could Gilead Sciences be lurking? That’s BioSci Capital Partners’ recent … |
TechCrunch |
All-star team of synthetic biologists raise $53 million for cancer therapy startup Senti
TechCrunch A who’s-who from the world of synthetic biological research have come together to launch Senti Biosciences with $53 million in funding from a slew of venture capital investors. Led by Tim Lu, a longtime researcher at the Massachusetts Institute of … |
TechCrunch |
All-star team of synthetic biologists raise $53 million for cancer therapy startup Senti
TechCrunch A who’s-who from the world of synthetic biological research have come together to launch Senti Biosciences with $53 million in funding from a slew of venture capital investors. Led by Tim Lu, a longtime researcher at the Massachusetts Institute of … We’re at the beginning of ‘a big new field of medicine’ — and one startup just got $53 million to supercharge itBusiness Insider Synthetic Bio Startup Senti Raises $53M to Program Cells to Treat DiseaseXconomy NEA powers next-generation cell and gene therapy startup Senti to $53MA roundFierceBiotech Chemical & Engineering News –PR Newswire (press release) all 7 news articles » |
TechCrunch |
All-star team of synthetic biologists raise $53 million for cancer therapy startup Senti
TechCrunch A who’s-who from the world of synthetic biological research have come together to launch Senti Biosciences with $53 million in funding from a slew of venture capital investors. Led by Tim Lu, a longtime researcher at the Massachusetts Institute of … |
TechCrunch |
All-star team of synthetic biologists raise $53 million for cancer therapy startup Senti
TechCrunch A who’s-who from the world of synthetic biological research have come together to launch Senti Biosciences with $53 million in funding from a slew of venture capital investors. Led by Tim Lu, a longtime researcher at the Massachusetts Institute of … |